HLS Therapeutics Inc.

HLS on TSXVToday's ChangeVolume52 Week Range (Low/Hi)Market Cap
9.19CAN -0.01/-0.11%4,2002.30 / 11.89155.31 M

Contact Information

HLS Therapeutics Inc.

Headquarters:
10 Carlson Court, Suite 410
Etobicoke, Ontario
Canada, M9W 6L2
Tel: 647-495-9000
Fax: 416-213-0045
Email: Send a message
Website: Visit website
For more information...
Lead: Laura Welsh

HLS is a specialty pharmaceutical company focused on the acquisition and commercialization of late stage development, commercial stage promoted and established, branded pharmaceutical products in the North American markets. HLS's focus is on products targeting the central nervous system and cardiovascular therapeutic areas. HLS's management team is composed of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages.

Greg Gubitz, BA, LLB - Chief Executive Officer

Gilbert Godin, BEng, MBA - President and Chief Operating Officer

Joe MacLean, BCom, LLB - Director, Corporate Development

Tim Hendrickson, MBA - VP Finance & Administration

Hemanth Varghese, PhD - Head of Corporate Strategy and Business Development

Ryan C. Lennox BA,JD - General Counsel

Sanjiv Sharma, MBA - VP Commercial Operations

Jason A. Gross, PharmD - VP Scientific Affairs

Carmel Daughtery, PMP - VP Integration Management

Bill Wells, BA, MBA - Executive Chairman of the Board

Greg Gubitz, BA, LLB - Chief Executive Officer

J. Spencer Lanthier - Director, Independent

Yvon Bastien - Director, Independent

Daniel Tassé - Director, Independent

Don DeGolyer - Director, Independent

Rodney Hill - Director, Independent

 

Stock Information

Company Overview

HLS is a specialty pharmaceutical company focused on the acquisition and commercialization of late stage development, commercial stage promoted and established, branded pharmaceutical products in the North American markets. HLS's focus is on products targeting the central nervous system and cardiovascular therapeutic areas. HLS's management team is composed of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages.

Management

Greg Gubitz, BA, LLB - Chief Executive Officer

Gilbert Godin, BEng, MBA - President and Chief Operating Officer

Joe MacLean, BCom, LLB - Director, Corporate Development

Tim Hendrickson, MBA - VP Finance & Administration

Hemanth Varghese, PhD - Head of Corporate Strategy and Business Development

Ryan C. Lennox BA,JD - General Counsel

Sanjiv Sharma, MBA - VP Commercial Operations

Jason A. Gross, PharmD - VP Scientific Affairs

Carmel Daughtery, PMP - VP Integration Management

Board of Directors

Bill Wells, BA, MBA - Executive Chairman of the Board

Greg Gubitz, BA, LLB - Chief Executive Officer

J. Spencer Lanthier - Director, Independent

Yvon Bastien - Director, Independent

Daniel Tassé - Director, Independent

Don DeGolyer - Director, Independent

Rodney Hill - Director, Independent

 

Contact Information

Headquarters:
10 Carlson Court, Suite 410
Etobicoke, Ontario
M9W 6L2, Canada
Telephone: 647-495-9000
Fax: 416-213-0045
Email: Send a message
Website: Visit website